American Oncology Network, Inc.

American Oncology Network, Inc. (Nasdaq: AONC) is a healthcare company focused on community-based oncology services that entered the public markets through a SPAC business combination. The blank-check vehicle that brought AONC public completed its IPO in 2021 and operated within the healthcare sector. The company filed an 8-K with the Securities and Exchange Commission on October 6, 2022, under accession number 0001104659-22-106540, reflecting a material corporate disclosure in the period following its de-SPAC transaction. American Oncology Network supports independent oncology physician practices across the United States, providing operational, administrative, and clinical infrastructure to community cancer care providers. Sign up at SpacDesk for complete filing history, sponsor details, and deal analytics on AONC and hundreds of other SPAC transactions.